Recent Finacing
Recent Raise
DermBiont is a clinical-stage biotech developing targeted topical small-molecule inhibitors (SM‑020 AKT, SM‑030 PKC‑β) and live bacterial therapeutics (DBI‑001), backed by microbial libraries and sequencing-driven discovery.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
